Anant S, Axenovich S A, Madden S L, Rauscher F J, Subramanian K N
Department of Genetics, College of Medicine, University of Illinois at Chicago 60612.
Oncogene. 1994 Nov;9(11):3113-26.
The tumor suppressor/developmental regulator protein WT1 encoded by the Wilms' tumor gene is a zinc finger-containing transcription factor which binds to the G+C-rich motif 5'-GCGGGGGCG-3' and represses transcription. Alternatively spliced variants of WT1 (termed+KTS) having an insertion in the zinc finger region are defective for binding to and hence for repression of transcription from promoters containing this motif. Due to the known interactions of two other tumor suppressor proteins with the simian virus 40 (SV40) oncoprotein large tumor antigen (TAg) [which in one case (p53) results in inhibition of the replication initiation activity of TAg], and because of the presence of G+C-rich sequences in the SV40 origin region, we tested the effect of WT1 on TAg- and SV40 origin-dependent DNA replication. WT1 and its alternatively spliced variants were found to be potent inhibitors of replication. Inhibition of replication by WT1 required portions of the N-terminal transcription repression domain and the C-terminal DNA binding domain, while other WT1 sequences needed for transcriptional regulation were dispensable. WT1 neither inhibited the synthesis of TAg nor formed a stable complex with it. Studies of the requirement of cis-active origin sequences in vivo and protein-DNA interactions in vitro indicated that WT1 and its alternatively spliced variants might inhibit replication by their novel binding to the GC box promoter motifs of the SV40 21 bp repeat replication-auxiliary sequence.
由威尔姆斯瘤基因编码的肿瘤抑制/发育调节蛋白WT1是一种含锌指的转录因子,它与富含G+C的基序5'-GCGGGGGCG-3'结合并抑制转录。WT1的选择性剪接变体(称为+KTS)在锌指区域有插入,因此在与含有该基序的启动子结合以及抑制转录方面存在缺陷。由于另外两种肿瘤抑制蛋白与猿猴病毒40(SV40)癌蛋白大肿瘤抗原(TAg)存在已知的相互作用[在一种情况下(p53)会导致TAg的复制起始活性受到抑制],并且由于SV40起源区域存在富含G+C的序列,我们测试了WT1对TAg和SV40起源依赖性DNA复制的影响。发现WT1及其选择性剪接变体是有效的复制抑制剂。WT1对复制的抑制需要N端转录抑制结构域和C端DNA结合结构域的部分区域,而转录调控所需的其他WT1序列则是可有可无的。WT1既不抑制TAg的合成,也不与之形成稳定的复合物。对体内顺式活性起源序列的需求和体外蛋白质-DNA相互作用的研究表明,WT1及其选择性剪接变体可能通过与SV40 21 bp重复复制辅助序列的GC盒启动子基序的新结合来抑制复制。